Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Mack, Natasha
52  Ergebnisse:
OpenAccess-Volltexte X
Personensuche X
?
1

Barriers and facilitators to pre-exposure prophylaxis (PrEP..:

Mack, Natasha ; Odhiambo, Jacob ; Wong, Christina M.
http://www.biomedcentral.com/1472-6963/14/231.  , 2014
Link: http://www.biomedcentral..
 
?
2

A toolkit for developing bilingual lexicons for internation..:

Ramirez, Catalina B ; Mack, Natasha ; Friedland, Barbara
https://knowledgecommons.popcouncil.org/departments_sbsr-hiv/305.  , 2013
Link: https://knowledgecommons..
 
?
3

Lost in translation: Assessing effectiveness of focus group..:

Mack, Natasha ; Ramirez, Catalina B ; Friedland, Barbara.
https://knowledgecommons.popcouncil.org/departments_sbsr-hiv/490.  , 2013
Link: https://knowledgecommons..
 
?
4

Implementing good participatory practice guidelines in the ..:

Mack, Natasha ; Kirkendale, Stella ; Omullo, Paul...
info:eu-repo/semantics/altIdentifier/doi/10.2147/OAJCT.S45717.  , 2013
Link: https://www.dovepress.co..
 
?
5

DTG regimen coverage among CLHIV ages 0–14 years, by quarte:

Caterina Casalini ; Yema D'Almeida ; Moussa Ariziki Nassam...
doi:10.1371/journal.pone.0296293.g001.  , 2023
Link: https://doi.org/10.1371/..
 
?
6

ART services provided to CLHIV/caregivers at baseline and e..:

Caterina Casalini ; Yema D'Almeida ; Moussa Ariziki Nassam...
doi:10.1371/journal.pone.0296293.t001.  , 2023
Link: https://doi.org/10.1371/..
 
?
7

#EAWA Togo data and graphs for July–September 2020 (baselin..:

Caterina Casalini ; Yema D'Almeida ; Moussa Ariziki Nassam...
doi:10.1371/journal.pone.0296293.s001.  , 2023
Link: https://doi.org/10.1371/..
 
?
8

National-level data on number of bottles with a one-month s..:

Caterina Casalini ; Yema D'Almeida ; Moussa Ariziki Nassam...
doi:10.1371/journal.pone.0296293.t004.  , 2023
Link: https://doi.org/10.1371/..
 
?
9

VL testing coverage and VLS among CLHIV, by quarter:

Caterina Casalini ; Yema D'Almeida ; Moussa Ariziki Nassam...
doi:10.1371/journal.pone.0296293.g003.  , 2023
Link: https://doi.org/10.1371/..
 
?
10

ART status and MMD coverage of CLHIV ages 0–14 years curren..:

Caterina Casalini ; Yema D'Almeida ; Moussa Ariziki Nassam...
doi:10.1371/journal.pone.0296293.t003.  , 2023
Link: https://doi.org/10.1371/..
 
?
11

VL testing coverage and VLS among CLHIV, by age group and q..:

Caterina Casalini ; Yema D'Almeida ; Moussa Ariziki Nassam...
doi:10.1371/journal.pone.0296293.g004.  , 2023
Link: https://doi.org/10.1371/..
 
?
12

DTG regimen coverage among CLHIV, by age group and quarter:

Caterina Casalini ; Yema D'Almeida ; Moussa Ariziki Nassam...
doi:10.1371/journal.pone.0296293.g002.  , 2023
Link: https://doi.org/10.1371/..
 
?
13

Demographic, clinical, and immunological characteristics of..:

Caterina Casalini ; Yema D'Almeida ; Moussa Ariziki Nassam...
doi:10.1371/journal.pone.0296293.t002.  , 2023
Link: https://doi.org/10.1371/..
 
?
14

Increasing multimonth dispensing of antiretrovirals and ass..:

Caterina Casalini ; Moses Bateganya ; Chris Akolo...
https://doi.org/10.1371/journal.pone.0286303.  , 2023
Link: https://doi.org/10.1371/..
 
?
15

Attitudes and perceptions towards novel objective measures ..:

Randy M Stalter ; Jenae Tharaldson ; Derek H Owen...
https://doi.org/10.1371/journal.pone.0180963.  , 2017
Link: https://doi.org/10.1371/..
 
1-15